Decline of Neurologic Varicella Complications in Children during the First Seven Years after Introduction of Universal Varicella Vaccination in Germany, 2005-2011

Pediatric Infectious Disease Journal

Volumn 36, Issue 1, 2017, Pages 79-86

  Streng, Andrea ^a   Grote, Veit ^b   Rack Hoch, Anita ^b   Liese, Johannes G ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

complication; surveillance; varicella vaccination; varicella zoster virus

Indexed keywords

ADOLESCENT; ATAXIA; BRAIN DISEASE; BRAIN INFARCTION; BRAIN VASCULITIS; CEREBRAL CONVULSION; CHICKENPOX; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CONVULSION; DISEASE ASSOCIATION; ENCEPHALITIS; FACIAL NERVE PARALYSIS; FAINTNESS; FEBRILE CONVULSION; FEMALE; GERMANY; HERPES ZOSTER ENCEPHALITIS; HOSPITALIZATION; HUMAN; ICD-10; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUROLOGICAL COMPLICATION; NEWBORN; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; TIME; VACCINATION; COHORT ANALYSIS; ENCEPHALITIS, VARICELLA ZOSTER; MENINGITIS, VIRAL; PRESCHOOL CHILD; SEIZURES; STATISTICS AND NUMERICAL DATA;

CHICKENPOX VACCINE;

ADOLESCENT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, VIRAL; SEIZURES; VACCINATION;

EID: 84991490791     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001356     Document Type: Conference Paper

References (32)

1. Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365-1376.
2. Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines. 2014;2:39-55.
3. Rack AL, Grote V, Streng A, et al. Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol. 2010;42:40-48.
4. Bozzola E, Tozzi AS, Bozzola M, et al. Neurological complications of varicella in childhood: case series and a systematic review of the literature. Vaccine. 2012;30:5785-5790.
5. Gilden D, Nagel MA, Cohrs RJ, et al. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep. 2013;13:374.
6. Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system-Prognosis, diagnostics and treatment. J Infect. 2015;71:281-293.
7. Persson A, Bergström T, Lindh M, et al. Varicella-zoster virus CNS disease-viral load, clinical manifestations and sequels. J Clin Virol. 2009;46:249-253.
8. Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep. 2009;9:430-434.
9. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut/Stand: Juli 2004. Epidemiologisches Bulletin. 2004;30:235-250.
10. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut/Stand: Juli 2009. Epidemiologisches Bulletin. 2009;30:279-298.
11. Spackova M, Muehlen M, Siedler A. Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J. 2010;29:884-886.
12. Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10:3594-3600.
13. Streng A, Grote V, Carr D, et al. Varicella routine vaccination and the effects on varicella epidemiology-results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011. BMC Infect Dis. 2013;13:303.
14. Bayerisches Landesamt für Statistik und Datenverarbeitung. Altersstruktur der Bevölkerung Bayerns. Available at: https://www.statistik.bayern.de/veroeffentlichungen/index.php?themenbereich=3100. Accessed December 8, 2015.
15. Liese JG, Grote V, Rosenfeld E, et al.; ESPED Varicella Study Group. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008;27:119-124.
16. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria; 2015. Available at: https://www.R-project.org.Accessed December 8, 2015.
17. Helmuth IG, Poulsen A, Suppli CH, et al. Varicella in Europe-A review of the epidemiology and experience with vaccination. Vaccine. 2015;33: 2406-2413.
18. Statistisches Bundesamt. Genesis-Online Datenbank. Available at: https://www-genesis.destatis.de/genesis/online. Accessed March 3, 2016.
19. Gowin E, Wysocki J, Michalak M. Don't forget how severe varicella can be-complications of varicella in children in a defined Polish population. Int J Infect Dis. 2013;17:e485-e489.
20. Marshall HS, McIntyre P, Richmond P, et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatr Infect Dis J. 2013;32:530-537.
21. Science M, MacGregor D, Richardson SE, et al. Central nervous system complications of varicella-zoster virus. J Pediatr. 2014;165:779-785.
22. Bozzola E, Bozzola M, Tozzi AE, et al. Acute cerebellitis in varicella: a ten year case series and systematic review of the literature. Ital J Pediatr. 2014;40:57.
23. Driesen Y, Verweij M, De Maeseneer M, et al. Vascular complications of varicella: description of 4 cases and a review of literature. Pediatr Infect Dis J. 2015;34:1256-1259.
24. Britton PN, Khoury L, Booy R, et al. Encephalitis in Australian children: contemporary trends in hospitalisation. Arch Dis Child. 2016;101:51-56.
25. Leung J, Harpaz R. Impact of the maturing varicella vaccination program on varicella and related outcomes in the United States: 1994-2012. J Pediatr Infect Dis Soc. 2015. Doi:10.1093/jpids/piv044.
26. Chi CY, Wang SM, Lin HC, et al. Complications of varicella infection in children in southern Taiwan. J Microbiol Immunol Infect. 2006;39:402-407.
27. Tan B, Bettinger J, McConnell A, et al; Members of the Canadian Immunization Monitoring Program, Active (IMPACT). The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008. Pediatr Infect Dis J. 2012;31:956-963.
28. Pahud BA, Glaser CA, Dekker CL, et al. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis. 2011;203:316-323.
29. Frenos S, Galli L, Chiappini E, et al. An increasing incidence of chickenpox central nervous system complications in children: what's happening in Tuscany? J Clin Virol. 2007;38:358-361.
30. Abdalrahman B, Laverty AA, Beckett G, Majeed A. Trends in hospital admission for varicella and zoster viruses in England, 2001/2002-2010/2011: time trend study. JRSM Open. 2015;6:1-6.
31. Dinleyici EC, Kurugol Z, Kara A, et al; VARICOMP Study Group. Children with breakthrough varicella infection requiring hospitalization in Turkey (VARICOMP Study 2008-2013). Vaccine. 2015;33:3983-3987.
32. Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev. 2013;26:728-743.